Using emotional labeling to help reduce cravings for cigarettes.
"Cue Labeling as a Tool to Regulate Craving During Abstinence from Smoking”.
['FUNDING_R21'] · UNIVERSITY OF CALIFORNIA-IRVINE · NIH-11035140
This study is looking at a helpful technique called Affect Labeling, where smokers learn to name their feelings to better manage cravings for cigarettes when they’re trying to quit, and it aims to see how this can make cravings easier to handle.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA-IRVINE (nih funded) |
| Locations | 1 site (IRVINE, UNITED STATES) |
| Trial ID | NIH-11035140 on ClinicalTrials.gov |
What this research studies
This research investigates a cognitive technique called Affect Labeling, which involves naming emotions to help manage cravings for cigarettes during periods of abstinence. The study aims to understand how this technique can reduce negative feelings and cravings by analyzing brain activity and self-reported experiences in smokers. Participants will engage in a task designed to help them label their emotions when exposed to smoking-related cues, potentially leading to better control over their cravings. The research will analyze data from previous studies to explore the relationship between emotional responses and cravings.
Who could benefit from this research
Good fit: Ideal candidates are adults aged 21 and older who are trying to quit smoking or have recently quit.
Not a fit: Patients who do not smoke or are not interested in quitting smoking may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide smokers with effective strategies to manage cravings and improve their chances of quitting.
How similar studies have performed: Previous studies have shown promise in using cognitive techniques to manage cravings, suggesting that this approach may be effective.
Where this research is happening
IRVINE, UNITED STATES
- UNIVERSITY OF CALIFORNIA-IRVINE — IRVINE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TABIBNIA, GOLNAZ — UNIVERSITY OF CALIFORNIA-IRVINE
- Study coordinator: TABIBNIA, GOLNAZ
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: addictive disorder